Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.8700
+0.0960 (12.40%)
At close: Jun 24, 2025, 4:00 PM
0.8570
-0.0130 (-1.49%)
Pre-market: Jun 25, 2025, 7:00 AM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $1.77 million as of June 25, 2025. Its market cap has decreased by -51.07% in one year.
Market Cap
1.77M
Enterprise Value
-1.94M
1-Year Change
-51.07%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $1.77M, a decrease of -98.05%. That is a compound annual growth rate of -57.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 1.57M | -59.22% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.48% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.83M | -28.42% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |